High-dose primaquine regimens against relapse of Plasmodium vivax malaria

American Journal of Tropical Medicine and Hygiene

Volumn 78, Issue 5, 2008, Pages 736-740

  Krudsood, Srivicha ^a   Tangpukdee, Noppadon ^a   Wilairatana, Polrat ^a   Phophak, Nantaporn ^a   Baird, J Kevin ^b   Brittenham, Gary M ^c   Looareesuwan, Sornchai ^d  

^a MAHIDOL UNIVERSITY   (Thailand)

^b ALERTAsia Foundation   (Indonesia)

^c Columbia University College of Physicians and Surgeons ^*  (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; CHLOROQUINE; MEFLOQUINE; PRIMAQUINE;

ABDOMINAL PAIN; ADULT; ANOREXIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALARIA; MALE; NAUSEA; PLASMODIUM VIVAX; RANDOMIZED CONTROLLED TRIAL; RELAPSE; THAILAND; VOMITING; WEAKNESS;

ARTESUNATE; PLASMODIUM VIVAX;

EID: 45349087314     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2008.78.736     Document Type: Article

References (31)

1. Krotoski WA, Colllins WE, Bray RS, Garnham PC, Gogswell FB, Gwadz R, Killick-Kendrick R, Wolf RH, Sinden R, Koontz LC, Stanfill PS, 1982. Demonstarion of hypnozoites in sporozoite transmitted Plasmodium vivax infection. Am J Trop Med Hyg 31: 1291-1293.
2. Mendis K, Sina BJ, Marchesini P, Carter R, 2001. The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg 64(Suppl): 97-106.
3. Bunnag D, Karbwang J, Thanavibul A, Chittamas S, Rattanapong Y, Chalermrut K, Bangchang KN, Harinasuta T, 1994. High dose of primaquine in primaqune resistant vivax malaria. Trans R Soc Trop Med Hyg 88: 218-219.
4. Looareesuwan S, Buchachart K, Wilairatana P, Chalermrut K, Rattanapong Y, Amradee S, Siripipat S, Chullavichit S, Thimasarn K, Ittiverakul M, Triampon A, Walsh DS, 1997. Primaquine-tolerant vivax malaria in Thailand. Ann Trop Med Parasitol 91: 939-943.
5. Doherty JF, Day JH, Warhurst DC, Chiodini PL, 1997. Treatment of Plasmodium vivax malaria - time for a change? Trans R Soc Trop Med Hyg 88: 218-219.
6. Looareesuwan S, Wilairatana P, Krudsood S, Treeprasertsuk S, Singhasivanon P, Bussaratid V, Chokejindachai W, Virayavejakul P, Chalermrut K, Walsh DS, White NJ, 1999. Chloroquine sensitivity of Plasmodium vivax in Thailand. Ann Trop Med Parasitol 93: 225-230.
7. Wilairatana P, Silachamroon U, Krudsood S, Singhasivanon P, Treeprasertsuk S, Bussaratid V, Phumratanaprapin W, Srivilairit S, Looareesuwan S, 1999. Efficacy of primaquine regimens for primaquine-resistant Plasmodium vivax malaria in Thailand. Am J Trop Med Hyg 61: 973-977.
8. Silachamroon U, Krudsood S, Treeprasertsuk S, Wilairatana P, Chalermrut K, Myint HY, Maneekan P, White NJ, Gourdeuk VR, Brittenham GM, Looareesuwan S, 2003. Clinical trial of oral artesunate with or without high-dose primaquine for the treatment of vivax malaria in Thailand. Am J Trop Med Hyg 69: 14-18.
9. Looareesuwan S, Wilairatana P, Glanarongran R, Indravijit KA, Supeeranontha L, Chinnapha S, Scott TR, Chulay JD, 1999. Atovaquone and proguanil hydrochloride followed by primaquine for treatment of Plasmodium vivax malaria in Thailand. Trans R Soc Trop Med Hyg 93: 637-640.
10. Bunnag D, Karbwang J, Thanavibul A, Chittamas S, Ratanapongse Y, Chalermrut K, Bangchang KN, Harinasuta T, 1994. High dose of primaquine in primaquine resistant vivax malaria. Trans R Soc Trop Med Hyg 88: 218-219.
11. Looareesuwan S, Wilairatana P, Krudsood S, Singhasivanon P, Treeprasertsuk S, Bussaratid V, Chokjindachai W, Viriyavejakul P, Chalermrut K, Walsh DS, White NJ, 1999. Chloroquine sensitivity of Plasmodium vivax in Thailand. Ann Trop Med Parasitol 93: 225-230.
12. Baird JK, Hoffman SL, 2004. Primaquine therapy for malaria. Clin Infect Dis 39: 1336-1345.
13. Clayman CB, Arnold J, Hochwald RS, Yount EH, Edgcomb JH, Alving AS, 1952. Toxicity of primaquine in Caucasians. JAMA 149: 1563-1568.
14. Hansen JE, Cleve EA, Pruitt FW, 1954. Relapse of vivax malaria treated with primaquine and report of one case of cyanosis (methemoglobinemia) due to primaquine. Am J Med Sci 227: 9-12.
15. Alving AS, Johnson CF, Tarlov AR, Brewer GJ, Kellermeyer RW, Carson PE, 1960. Mitigation of the hemolytic effect of primaquine and enhancement of its action against exoerythrocytic forms of the Chesson strain of Plasmodium vivax by intermittent regimens of drug administration. Bull World Health Organ 22: 621-631.
16. Charoenlarp P, Areekul S, Pholphoti T, Harinasuta T, 1973. The course of primaquine induced hemolysis in G6PD deficient Thais. J Med Assoc Thai 56: 392-397.
17. Buchachart K, Krudsood S, Singhasivanon P, Treeprasertsuk S, Phophak N, Srivilairit S, Chalermrut K, Ratttanapong Y, Supeeranuntha L, Wilairatana P, Brittenham GM, Looareesuwan S, 2001. Effect of primaquine standard dose (15 mg/day for 14 days) in the treatment of vivax malaria patients in Thailand. Southeast Asian J Trop Med Public Health 32: 720-726.
18. Looareesuwan S, Olliaro P, White NJ, Chongsuphajaisiddhi T, Sabcharoen A, Thimasarn K, Nosten F, Singhasivanon P, Supavej S, Khusmith S, Wyling S, Kanyok T, Walsh D, Leggat PA, Doberstyn EB, 1998. Consensus recommendation on the treatment of malaria in Southeast Asia. Southeast Asian J Trop Med Public Health 29: 355-360.
19. Baird JK, Rieckmann KH, 2003. Can primaquine therapy for vivax malaria be improved? Trends Parasitol 9: 115-120.
20. Looareesuwan S, White NJ, Chittamas S, Bunnag D, Harinasuta T, 1987. High rate of Plasmodium vivax relapse following treatment of falciparum malaria in Thailand. Lancet 2: 1052-1055.
21. Krudsood S, Wilairatana P, Mason DP, Treeprasertsuk S, Singhasivanon P, Looareesuwan S, 1999. Hidden Plasmodium falciparum infections. Southeast Asian J Trop Med Public Health 30: 623-624.
22. Mason DP, Krudsood S, Wilairatana P, Viriyavejakul P, Silachamroon U, Chokejindachai W, Singhasivanon P, Supavej S, McKenzie FE, Looareesuwan S, 2001. Can treatment of P. vivax lead to unexpected appearance of falciparum malaria? Southeast Asian J Trop Med Public Health 32: 57-63.
23. Snounou G, White NJ, 2004. The co-existence of Plasmodium: sidelights from falciparum and vivax malaria in Thailand. Trends Parasitol 20: 333-339.
24. Gustafsson LL, Walker O, Alvan G, Beermann B, Estevez F, Gliesner L, Lindstrom B, Sjoqvist F, 1983. Disposition of chloroquine in man after single intravenous and oral doses. Br J Clin Pharmacol 15: 471-479.
25. Baird JK, Wiady I, Fryauff DJ, Sutanihardja MA, Leksana B, Widjaya H, Kysdarmanto, Subianto B, 1997. In vivo resistance to chloroquine by Plasmodium vivax and Plasmodium falciparum at Nabire, Irian Jaya, Indonesia. Am J Trop Med Hyg 56: 627-631.
26. Walker O, Dawodu AH, Adeyokunnu AA, Salako LA, Alvan G, 1983. Plasma chloroquine and desethylchloroquine concentrations in children during and after chloroquine treatment of malaria. Br J Clin Pharmacol 16: 701-705.
27. White NJ, Milller KD, Churchill FC, Berry C, Brown J, Williams SB, Greenwood BM, 1988. Chloroquine treatment of severe malaria in children. Pharmacokinetics, toxicity, and new dosage recommendations. N Engl J Med 319: 1493-1500.
28. Beutler E, Glumbe KG, Kaplan JC, Lohr GW, Romot B, Valentine WN, 1979. International committee for standardization in hematology: recommended screening test for glucoses-phosphate dehydrogenase (G-6-PD) deficiency. Br J Haematol 43: 465-467.
29. Frank JE, 2005. Diagnosis and management of G6PD deficiency. Am Fam Physician 72: 1277-1282.
30. Baird JK, Basri H, Subianto B, Fryauff DJ, McElroy PD, Leksana B, Richie T, Lm Masbar S, Wignall FS, Hoffman SL, 1995. Treatment of chloroquine-resistant Plasmodium vivax with chloroquine and primaquine or halofantrine. J Infect Dis 171: 1678-1682.
31. Gogtay NJ, Kshirsagar NA, Vaidya AB, 2006. Current challenges in drug-resistant malaria. J Postgrad Med 52; 241-242.